Composition:
Mycophenolate Sodium Tablets USP 360 mg
Mycophenolic sodium (EC-MPS) is an enteric coated formulation of mycophenolate acid tablets that delivers the active moiety mycophenolic acid (MPA). EC-MPS was formulated in an attempt to overcome the upper GI adverse reactions associated with Mycophenolate mofetil (MMF). MPA is an immunosuppressant, non-competitive and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation to DNA. T-and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines. EC-MPS has demonstrated equivalent efficacy & safety compared to MMF.
*To be consumed as directed by physician.
